Data from the Oregon Adolescent Depression Project were used to examine the symptomatic expression of major depressive disorder (MDD) as a function of age and gender. The objective was to investigate the phenomenological nature of MDD among a cohort of adolescents as they progressed into early adulthood. The analyses were based on 564 participants who had experienced MDD in their lifetime. No systematic differences in the relative rate of occurrence of specific symptoms across episodes and only minor symptom differences between male and female participants were found. Age did not significantly influence the symptom picture. Stability of specific symptoms and episode severity across episodes was low. The results are discussed within the context of a stressor-symptom matching model.
Recent research has sought to establish the clinical features of major depressive disorder (MDD) in adolescents. Issues central to such research have included the epidemiology (e.g., prevalence, incidence, episode duration, comorbidity, and onset age), the symptomatic expression of MDD among adolescents (e.g., relative rate of occurrence of specific symptoms, gender and age effects), factors related to recurrence and chronicity (Lewinsohn, Rohde, Seeley, Klein, & Gotlib, 2000; Pettit, Lewinsohn, & Joiner, 2001) , and the treatment of depression (e.g., Hibbs & Jensen, 1996) .
Prior to the 1970s, depression among adolescents had received relatively little empirical attention. Indeed, some researchers maintained that depression did not exist in adolescents and that the criteria as listed in the Diagnostic and Statistical Manual of Mental Disorders (DSM; American Psychiatric Association, 1952) needed to be modified for use with adolescents (Glaser & Strauss, 1968; Toolan, 1962) . Nevertheless, investigations of depression in adolescence during the 1970s and early 1980s established the existence of clinically significant episodes of MDD during this age span, while also delineating some of the negative psychosocial effects associated with its occurrence (see Kazdin, 1988; Kovacs & Beck, 1977; Puig-Antich, 1982) . Moreover, in the mid-1980s and continuing throughout the 1990s, a substantial body of knowledge relating to MDD among adolescents has accrued. The Oregon Adolescent Depression Project (OADP) is among the studies that have provided information about depression in adolescence (e.g., Lewinsohn, Hops, Roberts, Seeley, & Andrews, 1993; Lewinsohn et al., 1994; Lewinsohn, Rohde, Klein, & Seeley, 1999; Lewinsohn, Rohde, & Seeley, 1998; Roberts, Lewinsohn, & Seeley, 1995) . The OADP is a large, prospective, epidemiological study of psychological disorders (particularly MDD) among a cohort of adolescents from the general community that was begun in the mid-1980s.
The results from the OADP (e.g., Roberts et al., 1995) suggest that the DSM criteria for depression are manifested by both adolescents and adults and that differences in the relative rates of occurrence of specific symptoms between adolescents and adults are relatively small. Out of the nine symptoms of a major depressive episode listed in the third edition of the DSM (DSM-III-R; American Psychiatric Association, 1987) , the mean number of symptoms for adolescents with MDD was 6.9 (SD ϭ 1.2). The most frequent symptoms were depressed mood (present among 97.7% of adolescents meeting criteria for MDD), sleep disturbances (present among 88.6%), difficulties thinking or concentrating (81.8%), weight or appetite disturbances (79.5%), and anhedonia (77.3%). As the DSM-III-R required the presence of either depressed mood or anhedonia for a diagnosis of major depression, it is not surprising that these were among the most common symptoms. The least frequent symptom was thoughts of death or suicide (54.5%).
In the present study, we extended the results of Roberts et al. (1995) by tracking these participants into early adulthood, paying careful attention to the potential changes in the symptomatic expression of depression as these adolescents entered adulthood. Furthermore, whereas Roberts et al. investigated symptoms across two depressive episodes, we tracked the symptomatic picture across four depressive episodes.
The results reported by Carlson and Kashani (1988) parallel those reported by Roberts et al. (1995) mentioned earlier. Both studies indicated that although the age difference between adoles-cence and adulthood may have a small effect on symptom prevalence, it does not alter the symptomatic expression of the disorder (see also Carlson & Strober, 1979; Friedman, Hurt, Clarkin, Corn, & Aronoff, 1983; Hudgens, 1974) . Nevertheless, a few differences in the overall symptom picture did emerge, including lower prevalence of complaints of fatigue, agitation, and poor appetite among adolescents. In addition, it appears that depressed adults as compared with adolescents have higher rates for initial and terminal insomnia and for weight loss (Carlson & Kashani, 1988; Carlson & Strober, 1979; Hudgens, 1974; Inamdar, Siomopoulous, Osborn, & Bianchi, 1979) . Moreover, several studies have reported elevated levels of suicidal behavior among adolescents and especially female adolescents (Carlson & Kashani, 1988; Carlson & Strober, 1979; Hudgens, 1974; Inamdar et al., 1979; Mitchell, McCauley, Burke, & Moss, 1988) .
Gender differences in symptomatic expression have also been investigated. As mentioned earlier, female adolescents are substantially more likely than male adolescents to be depressed. Roberts et al. (1995) found that among adolescents meeting criteria for a diagnosis of MDD, only two of the nine DSM-III-R symptoms differed significantly: weight/appetite disturbance and worthlessness/guilt. Females were significantly more likely than males to report both of these symptoms (77% vs. 59% for weight/appetite; 83% vs. 68% for worthlessness/guilt). Nevertheless, the failure to find significant gender differences among seven of the nine symptoms of MDD supports the notion that the symptomatology of MDD among adolescents is relatively uniform across genders. Kovacs (2001) also did not find any differences in the symptom pattern of male and female depressed adolescent patients.
All of the above-mentioned studies comparing adults and adolescents used a between-groups approach. That is, although a number of investigations have compared the symptomatic features of MDD between different groups of adolescents and adults, none (to our knowledge) have examined the symptom patterns of multiple depressive episodes between adolescence and young adulthood for the same group of individuals. The between-groups approach confounds cohort effects, whereas the within-group approach allows for an examination of developmental changes in depressive symptoms. Because of the longitudinal nature of the OADP, spanning the time period from adolescence to early adulthood, we were in a unique position to investigate two depressionrelated issues (i.e., adolescents vs. young adults, and across episodes). To wit: Are there systematic changes in the symptomatic expression of MDD between adolescence and young adulthood?
Another issue we were able to address concerns the stability of symptomatic expression across multiple episodes. Given the recurrent nature of depression (Angst, 1981; Fava, Rafanelli, Grandi, Conti, & Belluardo, 1998; Frank et al., 1990; Mueller et al., 1999; Thase & Sullivan, 1995) , knowledge about the stability or the lack of stability of specific depressive symptoms across episodes is important from a theoretical and from a clinical perspective. Two research groups have addressed this issue: Roberts et al. (1995) and Young and colleagues (Young, Fogg, Scheftner, & Fawcett, 1990) . Both examined the stability of symptoms in adolescents across two episodes of MDD. Roberts et al. reported that with the exception of depressed mood and anhedonia, concordance between symptoms during the first and second episodes was low in adolescents. The fact that the presence of one or the other of these two symptoms is required for a diagnosis of MDD would be expected to artificially inflate their concordance among people who meet criteria for diagnosis. Young et al. also found that the concordance of each symptom across episodes was low. Thus, the (albeit limited) literature to date suggests that symptom expression across episodes is highly unstable, and one of the goals of our study was to determine the magnitude of the concordance for specific symptoms across multiple episodes. On the basis of past empirical work (e.g., Roberts et al., 1995; Young et al., 1990) , however, we expected that across-episode symptom stability would be low.
Why might symptoms be (un)stable across episodes and vary between adolescents and adults and between gender? We would like to propose that particular symptoms may arise from one's environmental circumstances at the time of the depressive episode. This stressor-symptom matching hypothesis maintains that specific symptoms for an episode are determined by the nature of the stress that precedes the episode. This hypothesis may be understood to interact with formulations by Beck (1983) and Blatt, Quinlan, Shea, and Pilkonis (1995) , who have hypothesized that persons with certain stable personality traits (i.e., sociotropy, autonomy, and perfectionism) are vulnerable to depression if they experience particular classes of stressors. Thus, a person who is high on autonomy is hypothesized to be vulnerable to experiences of failure, whereas a person high on sociotropy is hypothesized to be vulnerable to experiences of social rejection. We are suggesting that the type of stress may also affect which symptoms are going to be manifested in a particular depression episode. (According to this, we would expect differences between males and females and between adolescents and adults to the extent that they experience different stressors, but we did not test this.)
Although we expected the symptomatic expression of MDD to be predominantly stable between genders, we expected that systematic gender variations might influence Criterion 3 (weight/ appetite disturbance). Given that females in general display a higher preponderance of eating-related problems (e.g., American Psychiatric Association, 1994; Lewinsohn et al., 1993; Woodside et al., 2001) , we expected that depressed females would be more likely than males to display weight and appetite disturbances (as reported by Roberts et al., 1995) . In contrast to weight and appetite disturbances, symptoms that are presumed to be at the core of MDD, such as depressed mood and anhedonia, were expected to be stable between genders.
In sum, the purpose of the present study was to compare the symptomatic nature of MDD among adolescents and young adults and to examine the stability of specific symptoms across episodes. In addition, we examined the differential expression of depressive symptoms between genders.
Method

Participants and Procedure
Participants were randomly selected from nine senior high schools representative of urban and rural districts in western Oregon. A total of 1,709 adolescents completed the initial (T 1 ) assessments (interview and questionnaires) between 1987 and 1989, with an overall participation rate of 61%. With minor exceptions, the adolescents in the T 1 sample were representative of high school students in western Oregon. Approximately half of the T 1 panel sample were female (53.7%), with an average age of 16.6 (SD ϭ 1.2). A total of 8.9% were non-White; 71.3% were living with two parents and 53% were living with two biological parents; and 12.3% had repeated a grade in school. Parental education level (maximum value for mother or father) was as follows: 1.9% had not completed high school, 16.1% had completed high school, 35.1% had a partial college education, and 46.9% had an academic or professional degree.
At the second assessment (T 2 ), 1,507 participants (88.1%) returned for a readministration of the interview and questionnaire (mean T 1 -T 2 interval ϭ 13.8 months, SD ϭ 2.3). There were few differences between participants and nonparticipants at T 1 (see Lewinsohn et al., 1993 Lewinsohn et al., , 1994 . Nevertheless, small but statistically significant differences emerged because of attrition in the T 1 -T 2 panel sample; attrition was associated with lower parental socioeconomic status, smaller household size, male gender, past diagnoses of disruptive behavior disorders, and past substance abuse disorders (boys only). There was no relation between depressive status and attrition. Additional details regarding the sample are provided in Lewinsohn et al. (1993) .
At age 24 (M ϭ 24.6 years, SD ϭ 0.61), all participants who met MDD diagnostic criteria at or any time before T 2 (n ϭ 360) or who met diagnostic criteria for nonmood disorders at or any time before T 2 (n ϭ 284), and an approximately equal number of young adults with no history of psychopathology by T 2 (n ϭ 457) were invited to participate in a T 3 evaluation. Of the 1,101 T 2 participants selected for a T 3 interview, 941 (85%) completed the age 24 evaluation. The various T 2 diagnostic groups did not differ on the rate of participation at T 3 .
Diagnostic Interviews
At T 1 , participants were interviewed with a version of the Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS) that combined features of the Epidemiological Version (Orvaschel, Puig-Antich, Chambers, Tabrizi, & Johnson, 1982) and the Present Episode Version (Chambers et al., 1985) and included additional items to derive diagnoses of past and current psychiatric disorders as outlined in the DSM-III-R. For the purposes of this study, it is important to note that the K-SADS provides operational definitions for different levels of severity for each symptom and that there was a prespecified level of severity that was required for the symptoms to be coded as present.
At T 2 and T 3 , participants were interviewed using the Longitudinal Interval Follow-Up Evaluation (LIFE; Shapiro & Keller, 1979) , which elicited detailed information about the course of psychiatric disorders since the previous evaluation. Diagnostic information was available regarding the occurrence, onset age, and duration of all disorders prior to and during the course of the study.
1 T 1 and T 2 diagnoses were made as per DSM-III-R criteria. All T 3 diagnoses were made using criteria from the fourth edition of the DSM (DSM-IV; American Psychiatric Association, 1994). Because the symptom requirements for DSM-III-R and DSM-IV are the same, we refer to DSM symptoms through the rest of the article. The interviewers rated the presence or absence of each of the nine DSM diagnostic symptoms. On the basis of a randomly selected subsample at T 1 (n ϭ 233), interrater reliability for lifetime diagnosis of MDD was excellent ( ϭ .86). For the T 2 -T 3 period (n ϭ 178), interrater reliability was again excellent ( ϭ .86). The interviewers also rated the presence or absence of functional impairment associated with the MDD episode in the spheres of social and family interactions and school.
Participant interviews at T 3 were conducted by telephone, which generally yields comparable results to face-to-face interviews (Rohde, Lewinsohn, & Seeley, 1997; Sobin et al., 1993; Wells, Burnam, Leake, & Robins, 1988) . Most of the interviewers had advanced degrees in clinical or counseling psychology or social work, and several years of clinical experience with diagnostic interviewing. All interviewers were trained in the use of the K-SADS and LIFE and had completed a minimum of two supervised training interviews, achieving a kappa greater than .80 for concordance between their symptom ratings and those of the supervisor.
Results
T 1 interrater reliabilities for the DSM and K-SADS MDD symptoms are presented in the first column of Table 1 . As can be seen, the interrater reliability for the majority of symptoms was good (K Ͼ .60). Among DSM symptoms, the mean kappa was .74, with excessive guilt ( ϭ .48) being the only symptom with a kappa of less than .60. Similarly, the mean kappa for interrater reliability among the K-SADS symptoms was .73, and only reactivity of mood ( ϭ .45) and social withdrawal ( ϭ .56) fell below .60.
Of the participants with available data at T 1 , T 2 , or T 3 , 564 (66% female) met DSM criteria for at least one major depressive episode in their lifetime (participants comorbid for other psychological disorders were included in order to maintain a more representative sample of the general population of individuals experiencing MDD). Of these, 224, or 40%, had experienced at least one recurrent episode. Seventy-nine (14%) of these individuals met symptom criteria for three depressive episodes, 31 (6%) of these 79 went on to experience a fourth episode, and 8 (1%) went on to experience a fifth episode. Finally, one individual (0.1%) had experienced seven depressive episodes by the age of 24. The recurrence rate found for MDD in this sample (40%) is lower than the recurrence rate reported in adults (i.e., 70%-80%; Angst, 1981; Fava et al., 1998; Frank et al., 1990; Mueller et al., 1999; Thase et al., 1995) . However, it is important to note that this rate of 40% recurrence occurred by the age of 24 and that the sample will have more recurrences as they get older.
Despite the approximately equivalent gender ratio in the overall sample (891 females, 818 males), almost twice as many females as males experienced episodes throughout the course of the study. The lifetime prevalence rate of depressive episodes at T 1 was 19% for the total sample (25% for females, 11% for males), 24% by T 2 (32% for females, 15% for males), and 43% by T 3 (53% for females, 31% for males; weighted for selection criteria).
2 These gender differences reached statistical significance at each time point, 2 (1, N ϭ 315) ϭ 51.20, 1 discriminant function, p Ͻ .001; 2 (1, N ϭ 392) ϭ 54.38, 1 discriminant function, p Ͻ .001; 2 (1, N ϭ 564) ϭ 56.18, 1 discriminant function, p Ͻ .001.
Females with an episode of MDD were also significantly more likely to experience recurrence than males before or during adolescence, 2 (1, N ϭ 45) ϭ 21.36, 1 discriminant function, p Ͻ .001 at T 1 ; 2 (1, N ϭ 82) ϭ 35.56, 1 discriminant function, p Ͻ .001 at T 2 . This pattern continued into young adulthood, 2 (1, N ϭ 224) ϭ 64.29, 1 discriminant function, p Ͻ .001, as almost one half (46%) of depressed females experienced at least two episodes by T 3 , compared with slightly over one fourth (27%) of depressed males who experienced at least two episodes. Approximately 42% of females experiencing a given depressive episode (be it their first, second, or third) 1 Only 34 participants had an initial onset of MDD before age 11 (6%), and only 1 participant had a second or third episode before age 11. Given such a low number of childhood onset of MDD cases, we are not able to address issues regarding childhood MDD. The focus of our study, consequently, is MDD among adolescents (Ͼ10 years) and young adults.
2 An unequal stratified sampling procedure was used for the T 3 diagnostic assessment. Of the 1,507 T 2 participants, all of those with a history of a DSM-III-R mental disorder (n ϭ 644) were selected to participate in the T 3 assessment. Of those with no history of mental disorder at T 2 (n ϭ 863), 457 participants were randomly selected to participate in the T 3 assessment.
had a recurrent episode. Among males, approximately 25% of those experiencing an episode proceeded to experience another depressive episode. Consequently, as the number of depressive episodes increased, the ratio of females to males also increased. Among those experiencing only one episode (n ϭ 340), 59% were female; among those who experienced two episodes (n ϭ 145), 73% were female; among those experiencing three episodes (n ϭ 48), 79% were female; and among those experiencing four episodes (n ϭ 23), 88% were female. Finally, only females experienced five or more episodes (n ϭ 7). 
Frequency of Symptoms Across Episodes
To ascertain the relative rate of occurrence of specific symptoms in adolescence and young adulthood, we examined the frequency and percentage of depressed persons experiencing each of the nine DSM symptoms within each episode. These frequencies and percentages are reported in the last four columns of Table 1 (note that these four columns correspond to MDD Episodes 1-4 and should not be confused with assessment times T 1 -T 3 , which are independent from MDD episode number). As can be seen, depressed mood was the most commonly experienced symptom across all episodes, with percentiles ranging from 90% to 95%. This is to be expected given that depressed mood is one of two symptoms that must be present for a diagnosis of major depression. The other symptom whose presence is considered sufficient by the DSM to allow for a diagnosis of MDD (provided other conditions are met) is markedly diminished interest or pleasure (anhedonia), which also had a high prevalence (range from 65% to 76%), but not as high as depressed mood.
In light of the special status accorded to depressed mood and loss of interest or pleasure (anhedonia) by the DSM, we investigated the concordance of these two symptoms in more detail. We found that of the total 564 individuals with a history of MDD, 376 (67%) concurrently experienced both depressed mood and anhedonia in Episode 1, 159 (28%) of depressed individuals experienced depressed mood without anhedonia, and 29 (5%) experienced anhedonia without coexisting depressed mood. A similar pattern was observed for the concordance of depressed mood and anhedonia in Episodes 2, 3, and 4.
The prevalence for the additional K-SADS symptoms and the impairment ratings are also shown in Table 1 . It is interesting to note that almost all of the depressive episodes were judged by the interviewers to be reactive in nature (i.e., with presence of a "precipitating" event). Tearfulness and crying was another frequently reported clinical characteristic, as was brooding about past experiences and irritability. The least common clinical characteristic was diurnal mood variation: worst in the a.m. (i.e., feeling more sad in the morning); a greater percentage felt worst in the p.m.
In order to establish stability of the prevalence of symptoms across episodes, we rank-ordered the DSM and additional K-SADS symptoms separately for each episode on the basis of relative frequency of occurrence within each episode for three adolescent and three adult episodes. For example, if depressed mood was the most commonly occurring symptom in the first episode, it received a rank of 1. This procedure was conducted separately for episodes occurring during adolescence (age Ͻ 18) and young adulthood (age Ն 18). Next, we correlated the rank order of the symptoms and clinical characteristics across episodes (Episodes 4 -7 were excluded for having a low sample size). The relative frequency of symptoms across episodes was high for both adolescents (mean r ϭ .94 for DSM symptoms; mean r ϭ .84 for the additional K-SADS symptoms) and young adults (mean r ϭ .93 for DSM symptoms; mean r ϭ .96 for K-SADS symptoms). In addition to across-episode comparisons, we correlated the rank order of symptoms between adolescents and young adults. Once again, the relative frequency of symptoms was highly stable between adolescents and adults. The mean combined correlation for all acrossage-group comparisons was .92 for DSM symptoms and .87 for the additional K-SADS symptoms. Thus, the relative frequency of symptoms was highly consistent across age groups and across episodes.
Stability of Symptoms Across Episodes
We examined the concordance of symptomatic expression across episodes for individuals. In other words, how much agreement exists in the presence or absence of a symptom in two different episodes? The question is, given that a person had symptom x in episode y, does this increase the probability for the presence of symptom x in episode y ϩ 1? Across-episode kappa values, and symptom positive and negative concordance percentages, are presented in Table 2 (Episodes 5-7 were excluded for having a low sample size).
Kappa values between Episodes 1 and 2 ranged from Ϫ.07 (impairment with family) to .32 (anhedonia), with a mean of .16. Among DSM symptoms, the most stable symptom was anhedonia, while the remaining DSM symptoms all had kappa values under .30 for symptom concordance between Episodes 1 and 2. Symptoms with lowest concordance rates included depressed mood, terminal insomnia, and worthlessness. It should be noted that the poor concordance on the depressed mood item resulted from those who were symptom negative (negative symptom concordance ϭ 11%). The K-SADS symptoms also displayed low concordances between Episodes 1 and 2; all had between-episode concordances under .30. The most stable characteristics were tearfulness/crying and demandingness/clinging (both s ϭ .25). The least stable characteristics included impairment with family ( ϭ Ϫ.07), brooding about past experiences ( ϭ .01), and mood reactivity (s ϭ .01). As can be seen in Table 2 , a similar pattern of low concordance between second and third episode symptoms and third and fourth episode symptoms was found. A similar pattern of low symptom concordance was found between a first episode experienced during adolescence and a subsequent episode experienced during young adulthood (mean ϭ .08, range ϭ Ϫ.12 to .29).
As a test of the stability of symptom level (severity), we examined the total number of symptoms experienced per episode for the first four episodes among female participants and among the first three episodes for male participants. The stability of the symptom counts were examined using (a) intraclass correlation coefficients (ICC) to determine concordance across episodes and (b) paired t tests to examine mean level changes across episodes. The mean numbers of the nine DSM symptoms and all 35 K-SADS symptoms, along with the across-episode ICCs and paired t tests, are reported in Table 3 separately by gender. As can be seen, the mean symptom counts were comparable across episodes. Among female participants, the only significant differences were found for mean level increases for both DSM and K-SADS symptom counts between the third and fourth episodes, paired t tests (27) ϭ Ϫ2.30 and Ϫ3.06, respectively. Among male participants, a significant increase in the mean K-SADS symptom count was found between the first and second episode, paired t test (51) ϭ Ϫ2.02. With respect to the concordance of symptom counts between episodes, all ICCs were less than .40 with the exception of the concordance between the third and fourth episodes among females (ICC ϭ .60). Thus, paralleling the specific symptom comparisons, the symptom counts also had low concordance across episodes. Last, the mean symptom counts for each episode were contrasted by gender. Significant differences were obtained for the first episode only; female participants had higher mean levels compared with male participants: for DSM (Ms ϭ 7.0 vs. 6.7), t(562) ϭ 2.89, p Ͻ .01; for K-SADS (Ms ϭ 17.6 vs. 16.4), t(562) ϭ 3.04, p Ͻ .01. 
Frequency and Stability of Symptoms Across Genders
We also investigated the similarity of symptom expression between males and females. Few differences consistently emerged between the genders across multiple episodes. Among the nine DSM-III-R symptoms, the most common variations were in the symptoms related to weight and appetite. In particular, females displayed greater fluctuation, with significant differences occurring for weight loss in Episodes 1, 2, and 3: t(562) ϭ 2.27, p Ͻ .05; t(222) ϭ 1.89, p ϭ .06; and t(94.6) ϭ 2.03, p Ͻ .05, respectively; and for weight gain in Episodes 3 and 4: t(65) ϭ 4.37, p Ͻ .001, and t(27) ϭ 3.58, p Ͻ .01, respectively. Analogously, significant differences in increased appetite were present in Episodes 1 and 4: t(562) ϭ 2.49, p Ͻ .05, and t(27) ϭ 3.29, p Ͻ .01, respectively.
Among the K-SADS symptoms, females were significantly more likely than males to report tearfulness and crying during Episodes 1, 2, and 4: t (562) 
Discussion
The present study investigated the continuity of MDD symptoms across episodes and from adolescence to early adulthood. Three central issues were addressed in this investigation: (a) the relative stability of specific depression symptoms between adolescence and early adulthood; (b) the concordance of specific MDD symptoms across adjacent depressive episodes; and (c) gender differences in the symptomatic expression of MDD. Each of these issues is discussed in turn, followed by a discussion of the study limitations, clinical implications, and directions for future research.
The fact that there are no systematic differences in relative symptom prevalence rates between adolescent and young adult episodes is consistent with other previous reports (i.e., Carlson & Kashani, 1988; Friedman et al., 1983; Hudgens, 1974) . The symptomatic expression of MDD appears to be similar among adolescents and adults on the basis of both clinical and community studies. To our knowledge, this is the first investigation to have demonstrated similarity of MDD symptomatic expression across different developmental periods within the same sample. The findings presented here provide further evidence that DSM criteria for MDD are appropriate for adolescents.
With respect to symptom concordance across adjacent episodes, the majority of the symptoms demonstrated relatively low concordance across episodes. Indeed, none of the symptoms would be considered to be highly concordant across the episodes (i.e., K Ͼ .50). The kappas were especially low for weight-and sleep-related symptoms, loss of energy, and whether there was impairment in family functioning. In other words, the results indicate that one cannot predict the recurrence of a symptom pattern from one episode to the next. Lack of consistency in symptom presentation across episodes is consistent with findings by Angst and Merikangas (1997) , who found that the majority of their cases who displayed a particular depression subtype on one episode displayed a different subtype on a subsequent episode.
Given that the DSM requires the presence of depressed mood or anhedonia to meet criteria for a major depressive episode, the stability of these two symptoms was expected to be high. Contrary to expectations, the chance-corrected concordance of depressed mood and anhedonia across episodes was low. The low kappas resulted from poor concordance among those who were symptom negative (i.e., low negative-agreement percentages). Another interesting finding involves the roles of depressed mood and anhedonia in MDD. According to one of the leading models of anxiety and depression, the tripartite model (Clark & Watson, 1991) , elevated negative affect and low positive affect are considered to be the defining characteristics of depression. Our results suggest that although this was true of approximately two thirds of depressed individuals, approximately 25% experienced depressed mood without anhedonia, and very few (approximately 5%) experienced anhedonia without depressed mood. Our results, while supporting the notion that anhedonia is a relatively frequent characteristic of MDD, indicate that depressed mood (negative affect) may play a more central role in the disorder.
In addition to the lack of stability of symptoms, the stability of number of symptoms (assumed to be a proxy for severity) was also low, and thus it appears that the severity of a subsequent episode cannot be predicted from the severity of the preceding episode. This lack of stability in specific symptoms and in severity provides a potential explanation for why it has been difficult to achieve consensus in depression subtypes (Lewinsohn, Zeiss, Zeiss, & Haller, 1977; Nierenberg, Pava, Rosenbaum, & Fava, 1996; Parker, 2000) on the basis of symptoms. As proposed earlier, we suggest that the reason for the lack of symptom stability is that specific symptoms for a particular episode may be influenced by environmental circumstances (e.g., the occurrence of specific stressful life events), which would be expected to vary over time.
In addition, the occurrence of specific stressors likely interacts with preexisting personality traits to impact symptom expression. Although we present the stressor-symptom matching model as a potential explanation for our findings of low across-episode symptom stability, we emphasize that we did not directly test the stressor-symptom matching hypothesis. Nevertheless, our findings are consistent with the model, and we present it in hopes of encouraging future research on the model. A prediction from this model is that individuals who are exposed to the same type of stressors across episodes would have greater stability. Thus, the stressor-symptom matching hypothesis can be tested by searching for relationships between specific stressors and specific depression symptoms.
The third central issue addressed in this study was the relative prevalence of symptoms between male and female participants. Our data suggest that males and females are remarkably similar with respect to their experience of MDD and that the same criteria may be applied to both genders for the purpose of diagnosis. The number of symptoms experienced per episode was also comparable between male and female cases. The comparability across genders found in this sample is consistent with recent results reported by Kovacs (2001) . Despite the similarity in symptom presentation between genders, female participants were much more likely to have recurrences. This finding is consistent with previous research by our group on adults (Lewinsohn, Zeiss, & Duncan, 1989) . It is also noteworthy that the female-male ratio increased dramatically with increasing number of episodes. In our sample, highly recurrent MDD before age 24 was an overwhelmingly female phenomenon.
Before we address the clinical implications of the findings, a discussion of the study limitations is warranted. First, although the study used a longitudinal design that tracked MDD episodes from adolescence to adulthood, retrospective reports of past episodes were used, which may have introduced biases due to selective recall. Second, data were available only up to age 24. Thus, prospective data from adolescence and data later in the life span were not available. Third, data regarding the severity and the duration of symptoms were not collected.
Because the null hypothesis was not rejected in most of our results (i.e., the relative prevalence of individual symptoms did not differ between adolescents and young adults, and there was relatively little concordance between specific symptoms across adjacent episodes) the veracity of the symptom data is a critical consideration. Confidence in the quality of our symptom data is bolstered by the following points: (a) The symptom data were elicited from the participants with carefully crafted probes; (b) the interviewers were provided with clear decision rules for judging the presence or absence of each symptom; (c) the interrater reliability for individual symptoms was at an acceptably high level; and (d) the relative frequency of occurrence of specific symptoms across episodes and across age and gender groups was stable and similar to what has been reported in studies with adolescent patients (e.g., Mitchell et al., 1988; Ryan et al., 1987) . Our suggestion that the lack of stability in symptom expression across episodes may be partially responsible for the failure of previous attempts to generate depression subtypes on the basis of symptoms does not negate the presence of stable symptom clusters (i.e., R-type factors; e.g., Cattell, 1965) across episodes. We intend to address the question as to whether dimensional structure of depression symptoms-as reported, for example, by Grinker, Miller, Sabshin, Nunn, and Nunnally (1961) -is stable across episodes in a future publication.
With respect to clinical implications, the results indicate that a careful assessment of individual symptoms for each episode is important. It should not be assumed that subsequent depressive episodes will resemble prior episodes with respect to symptom presentation. The extent that future research reveals associations between specific environmental conditions and MDD symptom presentation will have important implications for intervention strategies.
